Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director comp.
Director departure

Bioventus Inc. (BVS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 4/A NOHRA GUY P (Director) has filed a Form 4 on Bioventus Inc.
Txns: Disposed of 2,604,264 shares @ $0
08/23/2023 3/A NOHRA GUY P (Director) has filed a Form 3/A on Bioventus Inc.
08/22/2023 4 Bihl Anthony P III (Interim CEO) has filed a Form 4 on Bioventus Inc.
Txns: Bought 13,290 shares @ $4.1388, valued at $55k
Bought 26,595 shares @ $4.1388, valued at $110.1k
08/18/2023 4 NOHRA GUY P (Director) has filed a Form 4 on Bioventus Inc.
Txns: Acquired 41,369 shares @ $0
08/15/2023 4 Bartholdson John A. (10% Owner) has filed a Form 4 on Bioventus Inc.
Txns: Bought 50,037 shares @ $4.5953, valued at $229.9k
Bought 14,985 shares @ $4.7883, valued at $71.8k
08/15/2023 4 Juniper Investment Company, LLC (10% Owner) has filed a Form 4 on Bioventus Inc.
Txns: Bought 111,848 shares @ $4.47, valued at $500k
Bought 50,037 shares @ $4.56, valued at $228.2k
Bought 14,985 shares @ $4.79, valued at $71.8k
08/14/2023 4 Bartholdson John A. (10% Owner) has filed a Form 4 on Bioventus Inc.
Txns: Bought 111,848 shares @ $4.4741, valued at $500.4k
08/08/2023 10-Q Quarterly Report for the period ended July 1, 2023
08/08/2023 8-K Quarterly results
Docs: "Bioventus Reports Second Quarter Financial"
07/05/2023 4 CHURCH KATRINA J (SVP & Chief Compliance Officer) has filed a Form 4 on Bioventus Inc.
Txns: Sold 394 shares @ $2.83, valued at $1.1k
06/29/2023 3 Juniper Investment Company, LLC (10% Owner) has filed a Form 3 on Bioventus Inc.
06/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/16/2023 4 Bartholdson John A. (10% Owner) has filed a Form 4 on Bioventus Inc.
Txns: Bought 181,946 shares @ $3.2401, valued at $589.5k
Bought 110,180 shares @ $3.6092, valued at $397.7k
06/16/2023 SC 13D/A Juniper Investment Company, LLC reports a 10.7% stake in Bioventus, Inc.
06/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BIOVENTUS INC. 2023 RETENTION EQUITY AWARD PLAN",
"BIOVENTUS INC. 2023 RETENTION EQUITY AWARD PLAN"
06/08/2023 4/A CHURCH KATRINA J (SVP & Chief Compliance Officer) has filed a Form 4 on Bioventus Inc.
Txns: Sold 15 shares @ $14.07, valued at $211.1
Sold 58 shares @ $6.73, valued at $390.3
Sold 58 shares @ $7, valued at $406
06/08/2023 4 STALNECKER SUSAN M (Director) has filed a Form 4 on Bioventus Inc.
Txns: Exercised 16,648 restricted stock units @ $0
Granted 30,400 restricted stock units @ $0
06/08/2023 4 NOHRA GUY P (Director) has filed a Form 4 on Bioventus Inc.
Txns: Exercised 16,648 restricted stock units @ $0
Granted 30,400 restricted stock units @ $0
06/08/2023 4 NEELS GUIDO J (Director) has filed a Form 4 on Bioventus Inc.
Txns: Exercised 16,648 restricted stock units @ $0
Granted 30,400 restricted stock units @ $0
06/08/2023 4 McMurry-Heath Michelle (Director) has filed a Form 4 on Bioventus Inc.
Txns: Exercised 16,648 restricted stock units @ $0
Granted 30,400 restricted stock units @ $0
06/08/2023 4 Ladone Mary Kay (Director) has filed a Form 4 on Bioventus Inc.
Txns: Exercised 16,648 restricted stock units @ $0
Granted 30,400 restricted stock units @ $0
06/08/2023 4 HAWKINS WILLIAM A (Director) has filed a Form 4 on Bioventus Inc.
Txns: Exercised 16,648 restricted stock units @ $0
Granted 30,400 restricted stock units @ $0
06/08/2023 4 Beyer Pat (Director) has filed a Form 4 on Bioventus Inc.
Txns: Exercised 16,648 restricted stock units @ $0
Granted 30,400 restricted stock units @ $0
06/08/2023 4 Bartholdson John A. (Director) has filed a Form 4 on Bioventus Inc.
Txns: Exercised 7,576 restricted stock units @ $0
Granted 30,400 restricted stock units @ $0
05/26/2023 4 HAWKINS WILLIAM A (Director) has filed a Form 4 on Bioventus Inc.
Txns: Bought 44,000 shares @ $2.6907, valued at $118.4k
Bought 44,000 shares @ $2.6631, valued at $117.2k
05/26/2023 8-K Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits  Interact...
Docs: "Bioventus Completes Divestiture of",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION"
05/24/2023 4 Bihl Anthony P III (Interim CEO) has filed a Form 4 on Bioventus Inc.
Txns: Bought 125,000 shares @ $2.3279, valued at $291k
05/24/2023 SC 13D/A Juniper Investment Company, LLC reports a 9.5% stake in Bioventus, Inc.
05/23/2023 4 Bartholdson John A. (Director) has filed a Form 4 on Bioventus Inc.
Txns: Bought 1,136,675 shares @ $1.9362, valued at $2.2M
Bought 178,998 shares @ $2.0799, valued at $372.3k
05/16/2023 10-Q Quarterly Report for the period ended April 1, 2023
05/16/2023 8-K Quarterly results
Docs: "Bioventus Reports First Quarter Financial Results"
05/16/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Asset Purchase Agreement, by and among Misonix, LLC, Solsys Medical, LLC, Bioventus LLC and LifeNet Health",
"Bioventus Announces Divestiture of its Wound Business"
05/11/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/11/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Bioventus Reschedules Earnings Call to May 16, 2023 Files for Extension to File Form 10-Q for the Period Ended April 1, 2023"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy